SEC Form 4 · accession 0001209191-15-012891
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
G Bradley Cole
Officer — COO
Period of report
Feb 10, 2015
Accepted (ET)
Feb 12, 2015 · 5:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 10, 2015 | M | 4,000 | $9.39 | A | 25,645 | D | |
| Common StockF1,F2,F3,F4 | Feb 10, 2015 | S | 4,000 | $31.3671 | D | 21,645 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F5 | $9.39 | Feb 10, 2015 | M | 4,000 | D | — | Dec 1, 2015 | Common Stock | 4,000 | 29,664 | D |
Explanation of responses
- F1These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on November 24, 2014.
- F2Represents weighted average sale price. Actual sale prices ranged from $30.80 to $31.62.
- F3Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- F4Includes an aggregate of 12,655 shares of common stock issuable pursuant to previously reported restricted stock unit awards that have not vested.
- F5The option became exercisable as to 25% of the shares on December 1, 2006, and becomes exercisable as to 1/48th of the shares each full month thereafter.